Enterprise Financial Services Corp Has $226,000 Stake in HCA Healthcare, Inc. (NYSE:HCA)

Enterprise Financial Services Corp lowered its stake in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 5.3% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 753 shares of the company’s stock after selling 42 shares during the period. Enterprise Financial Services Corp’s holdings in HCA Healthcare were worth $226,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Whipplewood Advisors LLC bought a new position in shares of HCA Healthcare during the 4th quarter worth approximately $31,000. Legacy Investment Solutions LLC bought a new position in shares of HCA Healthcare during the 3rd quarter worth approximately $39,000. Activest Wealth Management raised its holdings in shares of HCA Healthcare by 1,250.0% in the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after purchasing an additional 125 shares during the period. Capital Performance Advisors LLP bought a new stake in shares of HCA Healthcare in the 3rd quarter worth approximately $41,000. Finally, Pinnacle Bancorp Inc. raised its holdings in shares of HCA Healthcare by 50.0% in the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock worth $45,000 after purchasing an additional 50 shares during the period. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

Shares of NYSE:HCA opened at $330.11 on Friday. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The firm has a fifty day simple moving average of $316.70 and a two-hundred day simple moving average of $347.49. The stock has a market capitalization of $81.27 billion, a P/E ratio of 15.03, a PEG ratio of 1.10 and a beta of 1.68.

HCA Healthcare (NYSE:HCAGet Free Report) last released its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the previous year, the firm posted $5.90 earnings per share. On average, analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be issued a dividend of $0.72 per share. The ex-dividend date is Monday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a yield of 0.87%. HCA Healthcare’s dividend payout ratio is 13.11%.

Analyst Ratings Changes

A number of equities research analysts recently commented on HCA shares. Barclays lowered their price target on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a report on Monday, January 27th. Truist Financial lowered their target price on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Bank of America lowered their target price on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, January 27th. KeyCorp reduced their price target on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. Finally, JPMorgan Chase & Co. restated a “neutral” rating and set a $380.00 price target on shares of HCA Healthcare in a research report on Tuesday, December 17th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $385.67.

Check Out Our Latest Report on HCA

Insiders Place Their Bets

In other news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares in the company, valued at $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.60% of the stock is currently owned by company insiders.

HCA Healthcare Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Further Reading

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.